5-MeO-MET: Difference between revisions

Latest revision as of 03:42, 13 February 2025

Overview[edit]

5-MeO-MET (5-methoxy-N-methyl-N-ethyltryptamine) is a psychedelic compound belonging to the tryptamine class. It is structurally related to other tryptamines such as 5-MeO-DMT and 5-MeO-DiPT. This compound is known for its psychoactive effects, which are similar to those of other 5-methoxy tryptamines.

Chemical Structure[edit]

5-MeO-MET is a synthetic compound with the chemical formula C13H18N2O. It features a methoxy group at the 5-position of the indole ring, a characteristic shared with other 5-methoxy tryptamines. The presence of the N-methyl-N-ethyl group distinguishes it from other related compounds.

Pharmacology[edit]

The pharmacological profile of 5-MeO-MET is not well-documented, but it is believed to act as a partial agonist at the 5-HT2A receptor, similar to other psychedelic tryptamines. This interaction is thought to be responsible for its psychoactive effects.

Effects[edit]

Users of 5-MeO-MET report a range of effects, including altered perception, enhanced mood, and visual hallucinations. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.

Legal Status[edit]

The legal status of 5-MeO-MET varies by country. In some jurisdictions, it may be classified as a controlled substance, while in others, it may be legal or unregulated. Users should be aware of the legal implications of possessing or using this compound in their region.

Related Compounds[edit]

Related Pages[edit]

@@ Line 1: / Line 1: @@
-{{Short description|A psychedelic compound}}
+{{DISPLAYTITLE:5-MeO-MET}}
-{{Drugbox
-| verifiedrevid = 477318123
-| IUPAC_name = 2-(5-Methoxy-1H-indol-3-yl)-N-methylethanamine
-| image = 5-MeO-MET.svg
-| image_size = 200px
-| legal_status = Unscheduled
-| routes_of_administration = Oral, Insufflation
-| CAS_number = 101717-60-0
-| PubChem = 44349264
-| ChemSpiderID = 23249924
-| UNII = 8X5V0Z0O3R
-| C=13 | H=18 | N=2 | O=1
-| smiles = CCN(C)CC1=CNC2=C1C=C(C=C2)OC
-}}
-'''5-MeO-MET''' (5-Methoxy-N-methyl-N-ethyltryptamine) is a [[psychedelic]] compound belonging to the [[tryptamine]] class. It is chemically related to other tryptamines such as [[5-MeO-DMT]] and [[5-MeO-DiPT]].
+== Overview ==
+'''5-MeO-MET''' (5-methoxy-N-methyl-N-ethyltryptamine) is a [[psychedelic]] compound belonging to the [[tryptamine]] class. It is structurally related to other tryptamines such as [[5-MeO-DMT]] and [[5-MeO-DiPT]]. This compound is known for its psychoactive effects, which are similar to those of other 5-methoxy tryptamines.
-==Chemical structure and properties==
+[[File:5-MeO-MET.svg|thumb|right|Chemical structure of 5-MeO-MET]]
--MeO-MET is a synthetic compound with the chemical formula C<sub>13</sub>H<sub>18</sub>N<sub>2</sub>O. It features a methoxy group at the 5-position of the indole ring, similar to other 5-methoxy tryptamines. The compound also includes an N-methyl-N-ethyl group attached to the ethylamine chain.
-==Pharmacology==
+== Chemical Structure ==
--MeO-MET acts as a [[serotonin receptor]] agonist, primarily affecting the [[5-HT2A receptor]]. This action is believed to be responsible for its psychedelic effects. The compound's pharmacological profile is similar to other 5-methoxy tryptamines, though specific binding affinities and metabolic pathways have not been extensively studied.
+-MeO-MET is a synthetic compound with the chemical formula C13H18N2O. It features a methoxy group at the 5-position of the indole ring, a characteristic shared with other 5-methoxy tryptamines. The presence of the N-methyl-N-ethyl group distinguishes it from other related compounds.
-==Effects==
+== Pharmacology ==
-The effects of 5-MeO-MET are reported to be similar to those of other psychedelic tryptamines, including altered perception, enhanced introspection, and changes in mood and cognition. Users have described visual and auditory hallucinations, as well as a sense of euphoria and spiritual experiences.
+The pharmacological profile of 5-MeO-MET is not well-documented, but it is believed to act as a partial agonist at the [[serotonin receptor|5-HT2A receptor]], similar to other psychedelic tryptamines. This interaction is thought to be responsible for its psychoactive effects.
-==Dosage and administration==
+== Effects ==
--MeO-MET is typically administered orally or via insufflation. The dosage range is reported to be between 5 to 20 milligrams, with effects lasting approximately 4 to 6 hours. As with all psychedelics, the effects can vary significantly based on individual physiology, set, and setting.
+Users of 5-MeO-MET report a range of effects, including altered perception, enhanced mood, and visual hallucinations. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
-==Legal status==
+== Legal Status ==
--MeO-MET is not specifically scheduled under the [[Controlled Substances Act]] in the United States, but it may be considered an analogue of other controlled tryptamines, making it potentially subject to prosecution under the [[Federal Analogue Act]]. Its legal status varies internationally.
+The legal status of 5-MeO-MET varies by country. In some jurisdictions, it may be classified as a controlled substance, while in others, it may be legal or unregulated. Users should be aware of the legal implications of possessing or using this compound in their region.
-==Safety and toxicity==
+== Related Compounds ==
-There is limited data on the safety and toxicity of 5-MeO-MET. As with other psychedelics, there is a potential for psychological distress, particularly in individuals with a predisposition to mental health disorders. Users are advised to exercise caution and ensure a safe environment when using the compound.
+* [[5-MeO-DMT]]
+* [[5-MeO-DiPT]]
+* [[5-MeO-MiPT]]
-==Related pages==
+== See Also ==
 * [[Tryptamine]]
 * [[Psychedelic drug]]
-* [[5-MeO-DMT]]
 * [[Serotonin receptor]]
+== Related Pages ==
+* [[List of psychedelic tryptamines]]
+* [[Psychedelic research]]
 [[Category:Psychedelic tryptamines]]
 [[Category:Serotonin receptor agonists]]